Gregor Brecl Jakob

6PUBLICATIONS
50CO-AUTHORS
Gene and molecular therapyNeurology and neuromuscular diseasesMedical infection agents (incl. prions)PharmacogenomicsCentral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 14, 2026
Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

|Mar 05, 2026
Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum Disorder.

Pakeeran Siriratnam, Vilija G Jokubaitis, Anneke Van Der Walt

|Jul 03, 2024
Progressive multifocal leukoencephalopathy in association with siponimod treatment for secondary progressive multiple sclerosis: a case report.

Uroš Rot, Miha Jerala, Alenka Horvat Ledinek

|Mar 04, 2024
Psychometric evaluation of the 5-item Medication Adherence Report Scale questionnaire in persons with multiple sclerosis.

Maj Jožef, Igor Locatelli, Gregor Brecl Jakob

|Sep 29, 2023
Medication persistence among people with multiple sclerosis in Slovenia treated with dimethyl fumarate.

Maj Jožef, Igor Locatelli, Gregor Brecl Jakob

|Feb 28, 2022
Acute cerebellitis requiring posterior fossa decompression after COVID-19 vaccination in an ocrelizumab-treated patient with multiple sclerosis.

Gregor Brecl Jakob, Lina Savšek, Bernard Meglič

Pageof 1

Frequent Collaborators

2 joint publications

Maj Jožef

2 joint publications

Izanne Roos

2 joint publications

Mitja Kos

2 joint publications

Allan G Kermode